产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 99% | 现货 | |||
| 5mg | 99% | 现货 | |||
| 10mg | 99% | 现货 | |||
| 50mg | 99% | 现货 | |||
| 100mg | 99% | 现货 | |||
| 250mg | 99% | 现货 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 99% | 现货 | |||
| 5mg | 99% | 现货 | |||
| 10mg | 99% | 现货 | |||
| 50mg | 99% | 现货 | |||
| 100mg | 99% | 现货 | |||
| 250mg | 99% | 现货 |
CAS No. |
1784751-19-4 |
|---|---|
中文名称 |
4-(2-(2-氟苯基)-4-(4-氟苯基)-1H-咪唑-5-基)吡啶 |
英文名称 |
4-(2-(2-Fluorophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)pyridine |
别名 |
TA-02;TA-02;TA02;TA 02;4-[2-(2-fluorophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]pyridine;Pyridine, 4-[2-(2-fluorophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-;TA-02,DMPK2,JNK2,TA02,CIT,CK1ε,JNK1,Inhibitor,LEF-1,TA 02,JNK3,BDNF,MEK5,Autophagy,DDR1 CK1δ,p38 MAPK,TCF,inhibit,COX-2;TA-02, 10 mM in DMSO;TA-02 (TA02;TA-02 ,S6807 |
标准英文名 |
4-(2-(2-fluorophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)pyridine |
MDL No. |
MFCD29924749 |
分子式 |
C20H13F2N3 |
分子量 |
333.34 |
精确分子量 |
333.11 |
SMILES |
FC(C=C1)=CC=C1C2=C(C3=CC=NC=C3)NC(C4=CC=CC=C4F)=N2 |
标准SMILES |
FC1C=CC(=CC=1)C1N=C(NC=1C1C=CN=CC=1)C1=CC=CC=C1F |
性状 |
Solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
QIFJOFNVIVQRNJ-UHFFFAOYSA-N |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
Sealed in dry,Store in freezer, under -20°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory tract irritation (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|